MDK is a chemokine that is upregulated in CRPC and associated to neuroendocrine differentiation [33] and as secreted protein has a strong prognostic potential measured in plasma from patients with hormone-sensitive metastatic prostate cancer (Nordin et al., unpublished). The gene discussed is MDK; the disease is metastatic prostate carcinoma.